Noninvasive VT ablation, Riata leads, NOAC/DOAC therapies, HDL-C and infection risk, and fibrosis in triathletes are discussed in this week’s podcast.
theheart.org on Medscape
Source link
Noninvasive VT ablation, Riata leads, NOAC/DOAC therapies, HDL-C and infection risk, and fibrosis in triathletes are discussed in this week’s podcast.
theheart.org on Medscape
Source link
Tidak ada komentar:
Posting Komentar